CAS 356547-88-1: Belimumab
Formula:Unspecified
- Synonyms:
- Benlysta
- LymphoStat B
- Belimumab
- Immunoglobulin G1, anti-(human BLyS) (human monoclonal LymphoStat-B heavy chain), disulfide with human monoclonal LymphoStat-B λ-chain, dimer
- Immunoglobulin G1, anti-(human cytokine BAFF) (human monoclonal LymphoStat-B heavy chain), disulfide with human monoclonal LymphoStat-B λ-chain, dimer
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Belimumab REF: TM-T76957CAS: 356547-88-1 | SDS-PAGE:98.4%;SEC-HPLC:98.4% | To inquire | Thu 27 Mar 25 |
 | Belimumab REF: 3D-CLA1649CAS: 356547-88-1 | - - - | To inquire | Tue 08 Apr 25 |
Belimumab
CAS:356547-88-1
Belimumab, a human IgG1λ monoclonal antibody, blocks BAFF, treating lupus and related fatigue.
Purity:
SDS-PAGE:98.4%;SEC-HPLC:98.4%
Color and Shape:
Liquid
Molecular weight:
144.07 kDa
Ref: TM-T76957
| 1mg | 48.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 27 Mar 2025
Ref: 3D-CLA1649
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 8 Apr 2025
